MASCT-I

· HRYZ Biotech Co.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MASCT-I, covering 2016-08-11 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 2]

See pricing